Advertisement

AJNR Awards, New Junior Editors, and more. Read the latest AJNR updates

Improved Turnaround Times | Median time to first decision: 12 days

Research ArticlePatient Safety
Open Access

What Does the Boxed Warning Tell Us? Safe Practice of Using Ferumoxytol as an MRI Contrast Agent

C.G. Varallyay, G.B. Toth, R. Fu, J.P. Netto, J. Firkins, P. Ambady and E.A. Neuwelt
American Journal of Neuroradiology July 2017, 38 (7) 1297-1302; DOI: https://doi.org/10.3174/ajnr.A5188
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. [email protected]
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests
CAPTCHA
Please verify that you are a real person

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Advertisement
Print
Download PDF
Email Article
Cite this article
0 Responses
Respond to this article
Bookmark this article
What Does the Boxed Warning Tell Us? Safe Practice of Using Ferumoxytol as an MRI Contrast Agent
C.G. Varallyay, G.B. Toth, R. Fu, J.P. Netto, J. Firkins, P. Ambady, E.A. Neuwelt
American Journal of Neuroradiology Jul 2017, 38 (7) 1297-1302; DOI: 10.3174/ajnr.A5188
del.icio.us logo Twitter logo Facebook logo Mendeley logo
Purchase

Jump to section

Advertisement